Three insights:
1. The ALIF implant is an anterior spinal implant that allows surgeons to expand it after insertion into the disc space.
2. It aims to provide patient specific adjustment, cut OR time and save costs for hospitals.
3. Initial testing recorded positive results. Ozop is incorporating improvements into the latest design and is seeking to complete testing for FDA submission shortly, with a goal of receiving approval by the end of the year.
“Developing an infinitely adjustable ALIF implant is a challenging design goal but the end outcome will allow the surgeon to ensure segmental stability and restore sagittal balance,” said Michael Chermak, CEO of Ozop.
More articles on devices:
MiMedx shakes up leadership after spying scandal — 3 insights
Aurora Spine revenues hit $2.73M in Q1 — 5 insights
Globus Medical launches expandable interspinous fixation system: 3 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
